Developing the Next generation of PFA for Cardiac Ablation
Lausanne, Switzerland
Joined April 2022
- Tweets18
- Following8
- Followers23
- Likes2
We are pleased to share that we closed a €54M oversubscribed Series B raise to advance our innovative Pulsed Field Ablation technology for treating #atrialfibrillation in the US and EU.
Learn more in our press release: argamedtech.com/news/f/arg%C…
Argá Medtech to present its CSE PFA platform at Stanford Biodesing New Arrhythmia technologies
argamedtech.com/news/f/arg%C…
Excited to share our poster presentation on Coherent Sine Burst Electroporation's first 5 patient case studies and 60-day follow-up at the AF Symposium in Boston.
#AFSymposium2023 #Arga #ArgaMedtech
News from #JPM2023!
Raised €10 Mil & achieved first-in-human in just 20 months with our Coherent Sine Burst Electroporation (#CSE) System for atrial fibrillation (#Afib) patients.
➡️ More by @MDDIonline with CEO David Neale: bit.ly/3HkNBCw
Congrats to our CEO David Neale for being one of the 30 #innovators to watch in 2022 - according to @Dsiliconreview.
🎙Learn more about #Arga in this Q&A with David: bit.ly/3EDgt6r
💡Full list of innovators at: bit.ly/3icPN4X
#Arga #Medtech #Startups
Thank you @holoniq for featuring us among the 200 most promising European #HealthTech #startups.
👉 Read more in the report and meet our fellow nominees at: bit.ly/3GF7moJ
#Arga #Medtech #Innovation #Europe
Thank you @MedTechOutlook for electing us as one of the top 10 #MedTech #startups in #Europe!
Atrial Fibrillation affects 33M + people worldwide, and treatments have a long-term success of 50-70%. Argá's technology addresses this issue.
➡️ More on bit.ly/3MDiBPt
We are excited to participate in @lsintelligence #Medtech Summit, an incredible opportunity to connect with other innovators and world-class investors.
📍 Check out our David Neale, CEO & Co-Founder presentation on Sept. 23 at 3 pm BST
#LSIEurope22 #MedicalDevices #Cardiology
ArgáMedtech retweeted
Atrial fibrillation is the most common irregular #heartbeat type and can lead to stroke or heart failure (@MayoClinic).
@ArgaMedtech developed a #CSE pulsed field ablation catheter, soon to start EU first-in-human #trial, to improve existing treatments🫀
✍️ ⬇️ @Medtech_Insight
Argá Medtech to present at LSI Emerging Medtech Euorpe 2022
lifesciencemarketresearch.co…
